Category: In Vitro Diagnostics
Global In Vitro Diagnostics
-
2024-2028 Global Methaqualone Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Georgia, ... Read More
-
2024-2028 Factor Assays Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Georgia, ... Read More
-
2024-2028 Prothrombin Time (PT) Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Asia-Pacific Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, ... Read More
-
2024-2028 Heparin-Induced Thrombocytopenia Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Georgia, ... Read More
-
Immunofluorescence Assays
... at a CAGR of 4.5% over the analysis period 2023-2030. Immunofluorescence Assays Reagents, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$3.8 Billion by the end ... Read More
-
In Vitro Diagnostics
... by 2030, growing at a CAGR of 3.4% over the analysis period 2023-2030. In Vitro Diagnostics Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and ... Read More
-
Automated Immunoassay Analyzers
... by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Immunofluorescence, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.2 Billion by the ... Read More
-
Clostridium Diagnostics
... at a CAGR of 14.1% over the analysis period 2023-2030. Immunoassays Technology, one of the segments analyzed in the report, is expected to record a 15.5% CAGR and reach US$9.1 Billion by the end of ... Read More
-
In-Vitro Colorectal Cancer Screening Tests
... is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 3.4% over the analysis period 2023-2030. Fecal Occult Blood Test, one of the segments analyzed in the report, is expected to record ... Read More
-
Human Papillomavirus (HPV) Testing
... reach US$1.8 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR ... Read More
-
Helicobacter Pylori Diagnostics
... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$436.9 Million by ... Read More
-
Clinical Risk Grouping Solutions
... 2030, growing at a CAGR of 13.7% over the analysis period 2023-2030. Scorecard & Visualization Tools, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$1.1 Billion ... Read More
-
Multiplex Assays
... at a CAGR of 6.4% over the analysis period 2023-2030. Protein Assays, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$2.5 Billion by the end of ... Read More
-
Mycotoxin Testing
... at a CAGR of 5.9% over the analysis period 2023-2030. Spectroscopy- & Chromatography-Based Testing, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$1.6 Billion by the ... Read More
-
Paper Diagnostics
... at a CAGR of 6.6% over the analysis period 2023-2030. Lateral Flow Assay Kits, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$6.7 Billion by the ... Read More
-
Herpes Marker Testing
... by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Diagnostic Centers End-Use, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$279.9 Million ... Read More
-
Nucleic Acid Labeling
... by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Nucleic Acid Labeling Reagents, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$2.4 ... Read More
-
Veterinary Hematology Analyzers
... at a CAGR of 5.3% over the analysis period 2023-2030. Table Top Analyzers, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.2 Billion by the end ... Read More
-
Rapid Medical Diagnostic Kits
... 2030, growing at a CAGR of 3.6% over the analysis period 2023-2030. Over the Counter (OTC) Kits, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$10.7 ... Read More
-
Cell Analysis
... CAGR of 5.5% over the analysis period 2023-2030. Flow Cytometry Products, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$10.3 Billion by the end of the ... Read More
-
The Global Microfluidics Market 2025-2035
... to revolutionize traditional approaches to diagnostics, drug development, and process control. Medical applications currently dominate market share, with point-of-care diagnostics and pharmaceutical research leading growth, while industrial applications in environmental monitoring, food safety, and process ... Read More
-
Nucleic Acid Isolation and Purification
... is expected to reach US$12.0 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2023-2030. Nucleic Acid Isolation and Purification Kits, one of the segments analyzed in the report, is expected ... Read More
-
Thyroid Function Tests
... by 2030, growing at a CAGR of 4.0% over the analysis period 2023-2030. TSH Tests, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.2 Billion by ... Read More
-
Point-of-Care Diagnostics: Technologies and Global Markets
... and market trends, including projections through 2029 and an analysis of key players. This report covers the entire industry, including hardware (devices, equipment, consumables), software, and analytics. The market is analyzed by test type, including ... Read More
-
Antithrombin
... of 5.2% over the analysis period 2023-2030. Therapeutics Application, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$847.5 Million by the end of the analysis period. ... Read More
Research Assistance
